Key facts
- This page summarizes David J. Wambeke's Form 4 filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2026, 08:49.
David J. Wambeke - 01 Mar 2026 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- NMTC
- Reported as of
- 01 Mar 2026
- Net transaction value
- +$670,400
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 08:49:19 UTC
- Prior SEC filing
- 03 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Emily Johns, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David J. Wambeke filed Form 4 for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 03 Jun 2025.
- Current net transaction value: +$670,400.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001971798
Primary reporting owner
Wambeke David J.
- Relationship
- Chief Business Officer
- Address
- 7599 ANAGRAM DRIVE, EDEN PRAIRIE
- Signature
- /s/ Emily Johns, by Power of Attorney
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NMTC
transaction
Common Stock
Purchase
- Transaction value
- $670,400
- Shares
- +1,000,000
- Change %
- Price
- $0.6704
- Shares after
- 1,000,000
- Date
- 01 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NMTC
transaction
Derivative
Option to Purchase Common Stock
Award
- Transaction value
- $0
- Shares
- +500,000
- Change %
- Price
- $0.000000
- Shares after
- 500,000
- Date
- 01 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500,000
- Exercise price
- $0.6704
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
25% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027.